SynthesisRenal failure2023
Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis.
Guo Yong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it
SynthesisRenal failure2023
Guo Yong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.